Inventor · disambiguated record
Steven W. Elmore
Also filed as: ELMORE STEVEN · ELMORE STEVEN W
57 granted patents·18 pending applications·1,783 citations·filing 1995–2024
99Inventor score
Top patents by PatentIndex Score
75 records- 0198US8546399B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2010·Granted Oct 1, 2013·100 cites·24 claims
- 0298US7973161B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jul 5, 2011·70 cites·5 claims
- 0398US7767684B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Aug 3, 2010·107 cites·7 claims
- 0498US7642260B2Apoptosis promotersABBOTT LAB·Filed 2005·Granted Jan 5, 2010·82 cites·2 claims
- 0598US7390799B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jun 24, 2008·331 cites·12 claims
- 0697US9174982B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Nov 3, 2015·38 cites·7 claims
- 0797US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0897US8580794B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Nov 12, 2013·44 cites·3 claims
- 0997US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 1097US8354404B2Apoptosis promotersABBOTT LAB·Filed 2011·Granted Jan 15, 2013·39 cites·8 claims
- 1197US8173811B2Apoptosis promotersBRUNCKO MILAN·Filed 2010·Granted May 8, 2012·50 cites·4 claims
- 1297US7709467B2Apoptosis promotersABBOTT LAB·Filed 2008·Granted May 4, 2010·50 cites·10 claims
- 1396US9034875B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 19, 2015·19 cites·1 claims
- 1496US9029404B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 12, 2015·19 cites·1 claims
- 1596US8614318B2Apoptosis promotersBRUNCKO MILAN·Filed 2006·Granted Dec 24, 2013·37 cites·2 claims
- 1696US8084607B2Apoptosis promotersBRUNCKO MILAN·Filed 2009·Granted Dec 27, 2011·43 cites·5 claims
- 1796US7842681B2Treatment of myeoproliferative diseasesABBOTT LAB·Filed 2007·Granted Nov 30, 2010·51 cites·8 claims
- 1896US7585858B2N-sulfonylcarboximidamide apoptosis promotersABBOTT LAB·Filed 2005·Granted Sep 8, 2009·19 cites·4 claims
- 1996US7449485B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2008·Granted Nov 11, 2008·19 cites·2 claims
- 2096US7358251B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2005·Granted Apr 15, 2008·19 cites·3 claims
- 2195US8343967B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2012·Granted Jan 1, 2013·32 cites·2 claims
- 2295US8114893B2Compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2009·Granted Feb 14, 2012·43 cites·20 claims
- 2394US9315488B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2015·Granted Apr 19, 2016·13 cites·2 claims
- 2494US9073855B2BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·2 claims
- 2594US9045420B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jun 2, 2015·11 cites·1 claims
- 2694US9045475B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Jun 2, 2015·14 cites·2 claims
- 2794US8952157B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Feb 10, 2015·22 cites·5 claims
- 2894US8426422B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesHEXAMER LAURA A·Filed 2010·Granted Apr 23, 2013·49 cites·4 claims
- 2994US6506766B1Glucocortiocoid-selective antinflammatory agentsABBOTT LAB·Filed 2000·Granted Jan 14, 2003·74 cites·35 claims
- 3093US8518970B2Compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2012·Granted Aug 27, 2013·29 cites·25 claims
- 3193US7906505B2Apoptosis promotersABBOTT LAB·Filed 2010·Granted Mar 15, 2011·18 cites·4 claims
- 3292US8232273B2Heterocyclic compounds and methods of useBAELL JONATHAN BAYLDON·Filed 2009·Granted Jul 31, 2012·28 cites·31 claims
- 3392US7030115B2N-sulfonylurea apoptosis promotersABBOTT LAB·Filed 2003·Granted Apr 18, 2006·32 cites·6 claims
- 3491US9303025B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Apr 5, 2016·11 cites·4 claims
- 3591US8338466B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesKUNZER AARON R·Filed 2010·Granted Dec 25, 2012·15 cites·6 claims
- 3690US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 3789US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 3889US7910742B2Survivin inhibitorsABBOTT LAB·Filed 2006·Granted Mar 22, 2011·9 cites·1 claims
- 3988US9345702B2Methods of treatment using selective Bcl-2 inhibitorsABBVIE INC·Filed 2014·Granted May 24, 2016·8 cites·12 claims
- 4087US7981888B21-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivativesABBOTT LAB·Filed 2008·Granted Jul 19, 2011·8 cites·7 claims
- 4187US7777076B2Macrocyclic inhibitors of BCL proteinsABBOTT LAB·Filed 2006·Granted Aug 17, 2010·6 cites·4 claims
- 4286US2025019364A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2024·Application pending·0 cites
- 4384US8188077B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDING HONG·Filed 2011·Granted May 29, 2012·8 cites·5 claims
- 4483US2024043404A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2023·Application pending·0 cites
- 4582US11897864B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2022·Granted Feb 13, 2024·0 cites·27 claims
- 4682US9067928B2Compounds and methods of useGENENTECH INC·Filed 2013·Granted Jun 30, 2015·5 cites·24 claims
- 4780US8445679B27-substituted indole MCL-1 inhibitorsWANG XILU·Filed 2008·Granted May 21, 2013·7 cites·4 claims
- 4876US9493411B2Pyrrole-3-carboxamide bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 15, 2016·3 cites·12 claims
- 4976US9035047B27-substituted indole Mcl-1 inhibitorsABBVIE INC·Filed 2013·Granted May 19, 2015·1 cites·4 claims
- 5075US2022315555A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →